Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Soy protein isolate with isoflavones does not prevent estradiol-induced endometrial hyperplasia in postmenopausal women: a pilot trial.

Murray MJ, Meyer WR, Lessey BA, Oi RH, DeWire RE, Fritz MA.

Menopause. 2003 Sep-Oct;10(5):456-64.

PMID:
14501608
2.

Effects of mammalian and plant estrogens on mammary glands and uteri of macaques.

Foth D, Cline JM.

Am J Clin Nutr. 1998 Dec;68(6 Suppl):1413S-1417S.

PMID:
9848509
3.

Effect of isoflavone soy protein supplementation on endometrial thickness, hyperplasia, and endometrial cancer risk in postmenopausal women: a randomized controlled trial.

Quaas AM, Kono N, Mack WJ, Hodis HN, Felix JC, Paulson RJ, Shoupe D.

Menopause. 2013 Aug;20(8):840-4. doi: 10.1097/GME.0b013e3182804353.

4.

Soy Isoflavones for Reducing Bone Loss Study: effects of a 3-year trial on hormones, adverse events, and endometrial thickness in postmenopausal women.

Alekel DL, Genschel U, Koehler KJ, Hofmann H, Van Loan MD, Beer BS, Hanson LN, Peterson CT, Kurzer MS.

Menopause. 2015 Feb;22(2):185-97. doi: 10.1097/GME.0000000000000280.

5.

A double-blind randomized study on the effects of red clover isoflavones on the endometrium.

Hale GE, Hughes CL, Robboy SJ, Agarwal SK, Bievre M.

Menopause. 2001 Sep-Oct;8(5):338-46.

PMID:
11528360
6.

Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial.

Kreijkamp-Kaspers S, Kok L, Grobbee DE, de Haan EH, Aleman A, Lampe JW, van der Schouw YT.

JAMA. 2004 Jul 7;292(1):65-74.

PMID:
15238592
7.

Soy Reduces Bone Turnover Markers in Women During Early Menopause: A Randomized Controlled Trial.

Sathyapalan T, Aye M, Rigby AS, Fraser WD, Thatcher NJ, Kilpatrick ES, Atkin SL.

J Bone Miner Res. 2017 Jan;32(1):157-164. doi: 10.1002/jbmr.2927. Epub 2016 Sep 6.

8.

Effects of soy protein isolate and moderate exercise on bone turnover and bone mineral density in postmenopausal women.

Evans EM, Racette SB, Van Pelt RE, Peterson LR, Villareal DT.

Menopause. 2007 May-Jun;14(3 Pt 1):481-8.

10.

One-year randomized study of the endometrial safety and bleeding pattern of 0.25 mg drospirenone/0.5 mg 17╬▓-estradiol in postmenopausal women.

Genazzani AR, Schmelter T, Schaefers M, Gerlinger C, Gude K.

Climacteric. 2013 Aug;16(4):490-8. doi: 10.3109/13697137.2013.783797. Epub 2013 May 11.

PMID:
23531117
11.

A pilot study of the effects of phytoestrogen supplementation on postmenopausal endometrium.

Balk JL, Whiteside DA, Naus G, DeFerrari E, Roberts JM.

J Soc Gynecol Investig. 2002 Jul-Aug;9(4):238-42.

PMID:
12113884
12.

Lack of effect of isoflavonoids on the vagina and endometrium in postmenopausal women.

Nikander E, Rutanen EM, Nieminen P, Wahlstr├Âm T, Ylikorkala O, Tiitinen A.

Fertil Steril. 2005 Jan;83(1):137-42.

PMID:
15652899
13.
15.

A mild favorable effect of soy protein with isoflavones on body composition--a 6-month double-blind randomized placebo-controlled trial among Chinese postmenopausal women.

Liu ZM, Ho SC, Chen YM, Ho YP.

Int J Obes (Lond). 2010 Feb;34(2):309-18. doi: 10.1038/ijo.2009.236. Epub 2009 Nov 17.

PMID:
19918248
16.

Effects of soy isoflavones and phytate on homocysteine, C-reactive protein, and iron status in postmenopausal women.

Hanson LN, Engelman HM, Alekel DL, Schalinske KL, Kohut ML, Reddy MB.

Am J Clin Nutr. 2006 Oct;84(4):774-80.

17.

Effects of trimonthly progestin administration on the endometrium in elderly postmenopausal women who receive hormone replacement therapy: a pilot study.

Pinto AB, Binder EF, Kohrt WM, Bronder DR, Williams DB.

Am J Obstet Gynecol. 2003 Jul;189(1):11-5.

PMID:
12861131
19.

Effects of a soy-based dietary supplement compared with low-dose hormone therapy on the urogenital system: a randomized, double-blind, controlled clinical trial.

Carmignani LO, Pedro AO, Montemor EB, Arias VA, Costa-Paiva LH, Pinto-Neto AM.

Menopause. 2015 Jul;22(7):741-9. doi: 10.1097/GME.0000000000000380.

PMID:
25423326
20.

Supplemental Content

Support Center